強直性脊椎炎 | Ankylosing Spondylitis

如你有此疾病,請遵照閣下醫生的完整醫療方案;而是否使用多學科復康方案前,你必須咨詢主診醫生的意見,如果閣下的主診醫生不建議您加入補充劑調理組合,請你不要使用。如果你需要尋求其他醫生作第二咨詢,閣下可聯絡我們線上<無邊界醫生>。或你自己城市內的其他專業醫生的再診斷。

强直性脊柱炎

强直性脊柱炎（AS）是一種慢性免疫介導的炎症性關節炎，被稱為脊柱關節炎（SpA）組。它通常發生在男性的第三個十年的生活和影響主要是軸向骨骼和骶髂關節。儘管最古老的描述可以追溯到加倫時代，但直到19世紀，根據弗拉基米爾·別赫捷列夫、阿道夫·斯特呂佩爾和皮埃爾·瑪麗的報告，才能够準確地診斷出這種疾病。已知HLA-B27等位基因與疾病1有很强的關聯；然而，其他基因在疾病的發展中也起了作用。多種炎症途徑的發現導致了生物治療時代的到來，這意味著AS治療和預後的一場革命。

Ankylosing spondylitis

Ankylosing spondylitis (AS) is a chronic immune-mediated inflammatory arthritis included in the so-called group of spondyloarthritis (SpA). It typically develops in males in their third decade of life and affects mainly the axial skeleton and the sacroiliac joints. Although the oldest descriptions date from the time of Galen, it was not until the 19th century that the disease could be accurately diagnosed on the basis of reports by Vladimir Bekhterev, Adolph Strümpell, and Pierre Marie. The HLA-B27 allele is known to have a strong association with the disease 1; however, other genes play a part in its development. The discovery of several inflammatory pathways led to the era of the biologic therapies, which meant a revolution in the treatment and prognosis of AS.